Purdue Pharma will pay more than $7 billion for the corporation's role in fueling the opioid epidemic that has killed hundreds of thousands of Americans. The Sackler family and Purdue Pharma reached a ...

Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...

Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday. The ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

NEW YORK (Reuters) -Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...

FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo/Douglas Healey, File) FILE - The Purdue Pharma offices are seen, May 8, 2007, in Stamford, Conn. (AP Photo ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...